<SEC-DOCUMENT>0001213900-22-049740-index.html : 20220819 <SEC-HEADER>0001213900-22-049740.hdr.sgml : 20220819 <ACCEPTANCE-DATETIME>20220819170122 ACCESSION NUMBER: 0001213900-22-049740 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20220819 DATE AS OF CHANGE: 20220819 EFFECTIVENESS DATE: 20220819 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Actinium Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001388320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880378336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-266996 FILM NUMBER: 221181489 BUSINESS ADDRESS: STREET 1: 275 MADISON AVENUE, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 646-677-3875 MAIL ADDRESS: STREET 1: 275 MADISON AVENUE, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: Cactus Ventures, Inc. DATE OF NAME CHANGE: 20070130 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>ea156670-s8_actiniumpharma.htm <DESCRIPTION>REGISTRATION STATEMENT <TEXT> Document 1 - file: ea156670-s8_actiniumpharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>ea156670ex5-1_actiniumpha.htm <DESCRIPTION>OPINION OF HAYNES AND BOONE, LLP. <TEXT> Document 2 - file: ea156670ex5-1_actiniumpha.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>ea156670ex23-1_actiniumpha.htm <DESCRIPTION>CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. <TEXT> Document 3 - file: ea156670ex23-1_actiniumpha.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.4 <SEQUENCE>4 <FILENAME>ea156670ex99-4_actiniumpha.htm <DESCRIPTION>THIRD AMENDMENT TO THE ACTINIUM PHARMACEUTICALS, INC. 2019 STOCK PLAN <TEXT> Document 4 - file: ea156670ex99-4_actiniumpha.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>5 <FILENAME>ea156670ex-fee_actiniumpha.htm <DESCRIPTION>FILING FEE TABLE <TEXT> Document 5 - file: ea156670ex-fee_actiniumpha.htm
</DOCUMENT> </SEC-DOCUMENT>